A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy
Titel:
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy
Auteur:
Leary, Alexandra Assersohn, L. Cunningham, D. Norman, A. R. Chong, G. Brown, G. Ross, P. J. Costello, C. Higgins, L. Oates, J.